Skip to main content

ProQR to Participate in Upcoming Investor Conferences

Written by Customer Service on . Posted in Public Companies.

LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA medicines for inherited retinal diseases (IRDs), today announced that Company management will participate in the following upcoming investor conferences:Citi’s 15th Annual BioPharma Virtual Conference
Thursday, September 10, 9:50-10:35 AM EST – Ophthalmology PanelH.C. Wainwright 22nd Annual Global Investment Conference
Tuesday, September 15, 1:30-1:50 PM EST – Fireside ChatCantor Virtual Global Healthcare Conference
Wednesday, September 16, 2:00-2:30 PM EST – Fireside ChatChardan Virtual 4th Annual Genetic Medicines Conference
Tuesday, October 6, 4:15-4:45 PM EST – Fireside ChatPresentation and webcast details can be found under ‘Events’ in the ‘Investors & Media’ section of the Company’s website (www.proqr.com). Archived webcasts will be available for approximately 30 days following the presentation date.About ProQR

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.